Clients benefit from MattsonJack's Science and Technology
Assessment consultants' unique combination of scientific and
corporate expertise. Each consultant conducts comprehensive
analysis and assessment.
Consultants with degrees in pharmacy, life
sciences and physical sciences provide technical and scientific
evaluation of therapeutic areas, pharmaceuticals, disease
states, medical devices and diagnostics. Consultants with
advanced business degrees, scientific backgrounds and industry
experience assist MattsonJack clients with strategic planning, market
and product assessments, market forecasting and licensing
opportunity evaluation.
Strengths include:
comparison and
scientific valuation of products and technology, including
oncology,
cardiovascular, central nervous system, antibiotics, bone,
dermatology, ophthalmic and
infectious diseases
determination of pipeline strengths
and weaknesses experience that results in
quick turnaround
Examples of expertise and previous projects
include but are not limited to:
Oncology
global strategy
in- and out-licensing opportunity
assessment
Cardiovascular
global strategy
ACE / NEP inhibitor market assessment
global partnering for products
Anti-Infective
septic shock market opportunities
strategic product planning
immunocompromised patient assessment
antifungal market assessment
Other
CNS opportunity assessment
evaluation of blood substitute
licensing opportunity
novel drug delivery system analysis
business plan development
infant / neonate product opportunity
assessment
abandoned approved NDA search
dermatology product identification
business development / corporate
partnering services
investment due diligence
For more information on MattsonJack's
Science and Technology Assessment services, phone (314)
469-7600 or e-mail info@mattsonjack.com.